about
Structure-Activity Relationships of a Series of Echinocandins and the Discovery of CD101, a Highly Stable and Soluble Echinocandin with Distinctive Pharmacokinetic PropertiesNovel antifungal agents: a patent review (2013 - present).Potent in vitro and in vivo antifungal activity of a small molecule host defense peptide mimic through a membrane-active mechanismSafety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults.Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.Pharmacokinetics of the Novel Echinocandin CD101 in Multiple Animal Species.Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi.Drugs in Clinical Development for Fungal Infections.Unraveling Drug Penetration of Echinocandin Antifungals at the Site of Infection in an Intra-Abdominal Abscess Model.Antifungal resistance: current trends and future strategies to combat.Biofilms and beyond: expanding echinocandin utility.Echinocandin prophylaxis in patients undergoing haematopoietic cell transplantation and other treatments for haematological malignancies.What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead.An introduction to the future of echinocandin therapy.MIC Distributions and Evaluation of Fungicidal Activity for Amphotericin B, Itraconazole, Voriconazole, Posaconazole and Caspofungin and 20 Species of Pathogenic Filamentous Fungi Determined Using the CLSI Broth Microdilution Method.Recent Insights into the Paradoxical Effect of Echinocandins.CD101, a Novel Echinocandin, Possesses Potent Antibiofilm Activity against Early and Mature Candida albicans Biofilms.
P2860
Q28817906-33A309C1-D3BD-445F-8874-8F72E2E8ED08Q30239745-783DDDDD-394F-4EB1-B3BF-D0E226D86AD4Q33849225-2D3B5800-7118-4B98-B100-B78706A273BFQ37612980-F753022F-7BF6-4A1C-83D9-20A0960E8333Q37669855-F3F6DEBE-D95C-407E-B042-92DDEA09AF5DQ37720796-E403CADB-8754-437B-B683-B9F7E03B1650Q40045666-F8BE49AC-D6D8-47C1-A439-E22D9DCBA09CQ40070714-9589C96A-CB12-4377-984B-D2841CFC1933Q40121744-010CECB5-A155-437A-BF10-FA9C93FA07BEQ41632930-515F630F-D717-4512-BDCE-091B88583FC8Q47205366-2D049D79-78D0-45CF-A3B4-5DB5F277BB55Q47205373-921577B9-2AE5-4897-BE1A-AC24A2318030Q47749829-E34ABD6F-5F88-4E8A-9D86-0397F612BA5BQ47749857-E4551AB4-EFE8-4CB5-8FEE-5509C2B8D270Q49679755-FBF38BB3-43BD-46AA-B43D-3DC4626AFB69Q49679966-DE15D203-720B-4FFA-857B-81AB6A341974Q50042600-51F55251-D9F0-4115-9001-F25D64CB9ACF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 June 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
CD101: a novel long-acting echinocandin.
@en
CD101: a novel long-acting echinocandin.
@nl
type
label
CD101: a novel long-acting echinocandin.
@en
CD101: a novel long-acting echinocandin.
@nl
prefLabel
CD101: a novel long-acting echinocandin.
@en
CD101: a novel long-acting echinocandin.
@nl
P2093
P2860
P356
P1476
CD101: a novel long-acting echinocandin.
@en
P2093
Cristina Jiménez-Ortigosa
David S Perlin
Grayson Hough
Jeffrey B Locke
Ken Bartizal
Winder B Perez
Yanan Zhao
P2860
P304
P356
10.1111/CMI.12640
P577
2016-06-28T00:00:00Z